Abstract
The novel coronavirus disease 2019 (COVID-19) has changed our lives and reshaped our approach to management of various cardiovascular diseases. Ventricular tachycardia (VT) is a potentially life-threatening arrhythmia, most often seen in patients with structural heart disease. If underlying ischemia is suspected, coronary angiography is usually performed on a non-elective basis. In patients with active COVID-19, additional risks of the procedure must be considered for patients and for operators. This case illustrates the management of suspected ischemic VT and discusses the dilemma physicians must face in the ongoing COVID-19 pandemic.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
